site stats

Gelesis investor relations

WebGelesis is a biotechnology company located in Boston, Massachusetts that developed the weight loss device Gelesis100 (Plenity) for use in overweight and obesity. The company … WebJul 19, 2024 · Gelesis and Capstar will host a joint investor conference call to discuss the transaction today, July 19, 2024, at 8:30 a.m. Eastern Time. A telephone replay of the …

Gelesis Holdings, Inc. (GLSH) SEC Filings Nasdaq

WebAug 23, 2024 · Investor Presentation Virgin Orbit Home Vision Launch The Virgin Way Missions Investor Information Careers Orbit for Everyone Team Contact Us The Latest … WebInvestors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ... henry 430 https://codexuno.com

Gelesis to Report Full Year 2024 Financial Results on March 24, 2024

WebMar 28, 2024 · A pre-recorded webcast discussing these results is available on the “Events & Presentations” section of the Gelesis Investor Relations website at … WebGelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease ... WebAug 15, 2024 · Gelesis management will host a conference call today at 8:30 am ET to discuss the second quarter 2024 results, followed by a question-and-answer period. The … henry 422 fortify

Gelesis to Participate in the Jefferies Virtual Fitness & Wellness …

Category:Capstar Special Purpose Acquisition : Gelesis, a Consumer …

Tags:Gelesis investor relations

Gelesis investor relations

Gelesis Holdings, Inc. (GLSH) After-Hours Quotes Nasdaq

WebMar 28, 2024 · BOSTON-- ( BUSINESS WIRE )-- Gelesis Holdings, Inc. (NYSE: GLS) (“Gelesis” or the “Company”), the maker of Plenity for weight management, today … WebApr 10, 2024 · Investor Relations Business Wire NYSE to Suspend Trading Immediately in Gelesis Holdings, Inc. (GLS) and Commence Delisting Proceedings Provided by Business Wire. Apr 10, 2024 8:24 PM UTC ...

Gelesis investor relations

Did you know?

WebInvestor Relations. Genesis Healthcare, Inc. (OTC Expert Market: GENN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's … WebJul 19, 2024 · The conference call can be accessed via webcast on Gelesis’ investor relations website at gelesis.com/investors, or by dialing +1 844-512-2921 within the …

WebAug 4, 2024 · Gelesis management will host a live conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. The live call can be accessed via webcast on …

WebNov 14, 2024 · Gelesis Reports Third Quarter 2024 Results Published: Nov 14, 2024 Plenity quarterly product revenue increased 114% year-over-year to $6.4 million, with 23,500 new members and 92,000 units sold in Q3 Quarterly gross profit increased by $2.6 million year-over-year, with gross margin improving from 8% to 44% WebNov 7, 2024 · Gelesis is a consumer-centered biotherapeutics company and the maker of Plenity for weight management. (Photo: Business Wire) The live call can be accessed via webcast on the "Events &...

WebMar 24, 2024 · BOSTON, March 24, 2024--Gelesis (NYSE: GLS), the maker of Plenity for weight management, today reported financial results for its fiscal year ended December 31, 2024.

WebMar 28, 2024 · Product revenue, net, was $25.6 million in 2024 compared to $11.2 million in 2024, a 129% increase year-over-year. In the second half of 2024, we significantly reduced sales and marketing ... henry 422 adhesiveWebFind the latest on option chains for Gelesis Holdings, Inc. (GLSH) at Nasdaq.com. henry 420 blacktop driveway crack patchWebMay 9, 2024 · Gelesis management will host a live conference call and webcast at 4:30 p.m. ET on the same day to discuss the results. Conference Call Details Date: Thursday, May 12, 2024 Time: 4:30 p.m.... henry 430 adhesive sdsWebJan 14, 2024 · BOSTON, MA & AUSTIN, TX, January 13, 2024 – Gelesis, the maker of Plenity ®, an FDA-cleared weight management approach, announced today the completion of its business combination with Capstar... henry 430 adhesive specsWebSelect time range to see more trades: Last 100 Trades. After Hours Time (ET) After Hours Price. After Hours Share Volume. 18:29:19. $0.012. henry 430 adhesive installationWebMar 17, 2024 · Investor Relations: ICR Lynne Collier [email protected] 646-430-2216 Media Relations: Katie Sullivan [email protected] henry 430 adhesive instructionsWebNov 14, 2024 · Gelesis Reports Third Quarter 2024 Results Business Wire November 14, 2024, 7:00 AM · 24 min read Plenity quarterly product revenue increased 114% year-over-year to $6.4 million, with 23,500 new... henry 430 adhesive coverage